
What happened
Precision Optics Corporation, Inc. (NASDAQ: POCI) said fiscal 2026 revenue reached a record $31.5 million for the year ended June 30, 2026. Quarterly revenue was a record $8.8 million, up from $6.2 million in the same quarter a year earlier and $8.7 million in the most recent sequential quarter. Production revenue was $28.1 million for the year and $8.0 million for the quarter.
Cash and cash equivalents were $9.8 million at June 30, 2026, up from $1.8 million a year earlier. The company said it received a $1.3 million follow-on production order from a large defense company and is still ramping a previously announced $3.5 million follow-on order for the single-use ophthalmic program.
It also recently announced an initial engineering order from a U.S. space technology company and appointed Peter Thier as Senior Vice President of Sales and Marketing.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Fiscal 2026 revenue | $31.5 million | from $19.1 million, + $12.4 million | SEC 8-K |
| Production revenue | $28.1 million | from $14.2 million, + $13.9 million | SEC 8-K |
| Gross margin | 17.2% | from 17.8%, -0.6 percentage points | SEC 8-K |
| Net loss | $(3.6) million | from $(5.8) million, + $2.2 million | SEC 8-K |
| Adjusted EBITDA | $(2.1) million | from $(3.7) million, + $1.6 million | SEC 8-K |
| FY 2027 revenue guidance | in the range of $30 million to $33 million | SEC 8-K |
Why it matters
FY 2026 revenue increased by $12.4 million from $19.1 million, a jump of about 65%. Revenue was a fiscal year record at $31.5 million. Production revenue rose to $28.1 million from $14.2 million.
Gross margin was 17.2% for the year, down from 17.8%. The quarter showed 25.3% gross margin and positive Adjusted EBITDA of $0.4 million.
The company's case is that design wins must turn into higher-margin production before cash burn forces financing. This filing is mixed because fiscal 2027 revenue guidance is $30 million to $33 million, similar to fiscal 2026, and Adjusted EBITDA is expected to stay negative. The outlook reflects a pause in demand from the existing satellite customer. It also cites growth in single-use medical device programs, renewed defense production, additional programs moving into production and new engineering engagements.
What's next
Today's 5:00 p.m. ET conference call is next. The company said it expects a stronger second half as orders are expected to resume from the existing satellite customer.
That timing will matter for the revenue range and the negative Adjusted EBITDA outlook.
Sources
- SEC 8-K — Exhibit 99.1 press release and financial tables dated September 28, 2026.
Read the full OptimistFi thesis on Precision Optics Corporation, Inc.: https://optimistfi.com/stocks/POCI
See what would break the Precision Optics Corporation, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Precision Optics Corporation, Inc. investment case, its status and the next test to watch live on the Precision Optics Corporation, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
